Completed PHASE4 INTERVENTIONAL 4-arm NCT02935855

ORal anticoaGulants in diAbetic and Nondiabetic Patients With nOn-valvular Atrial fibrillatioN (ORGANON) (ORGANON)

Efficacy and Safety of Non-vitamin K Oral Anticoagulants and Vitamin K Oral Anticoagulants on Some Metabolic and Coagulation Parameters in Diabetic and Nondiabetic Patients With First Diagnosis of Non-valvular Atrial Fibrillation

Sponsor: University of Pavia

Conditions Diabetes

Interventions Acenocumarole Apixaban Dabigatran Edoxaban Rivaroxaban Warfarin

Updated 7 times since 2017 Last updated: Nov 8, 2020 Started: Sep 30, 2015 Primary completion: Apr 30, 2019 Completion: Sep 30, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE4 clinical study on Diabetes, this trial is completed. The trial is conducted by University of Pavia and has accumulated 7 data snapshots since 2015. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Dec 2020 — Jan 2021 [monthly]

Completed PHASE4

Status: Unknown Status → Completed
Nov 2018 — Dec 2020 [monthly]

Unknown Status PHASE4

Status: Recruiting → Unknown Status

▶ Show 2 earlier versions

Jun 2018 — Nov 2018 [monthly]

Recruiting PHASE4
Jan 2017 — Jun 2018 [monthly]

Recruiting PHASE4

First recorded

Sep 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

University of Pavia

Data source: University of Pavia

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Pavia, Italy